Venous thromboembolism (VTE) prophylaxis

Last reviewed: 28 Oct 2022
Last updated: 29 Sep 2022

Summary

Definition

History and exam

Key diagnostic factors

  • previous VTE, thrombophilia, malignancy, postoperative setting, trauma, and indwelling central catheter
  • chronic medical conditions, paresis, increasing age, obesity, oestrogen-containing contraceptive pills and hormone replacement therapy, varicose veins, pregnancy and up to 6 week postnatal, first-degree relative with a history of VTE, extended travel, and admission to intensive care
More key diagnostic factors

Risk factors

  • previous VTE (deep vein thrombosis [DVT] and/or pulmonary embolism [PE])
  • thrombophilia
  • malignancy
  • postoperative setting
  • trauma
  • indwelling central catheter (upper or lower extremity)
  • immobility
  • myeloproliferative diseases
  • congestive heart failure
  • chronic obstructive pulmonary disease
  • inflammatory bowel disease
  • neurological disease with extremity paresis
  • increasing age
  • obesity
  • oestrogen-containing contraceptive pills, hormone replacement therapy (HRT), and androgen deprivation therapy
  • history of varicose veins
  • pregnancy/postnatal
  • extended travel
  • lower leg immobility
  • first-degree relative with a history of VTE
  • admission to intensive care
More risk factors

Diagnostic investigations

1st investigations to order

  • FBC
  • serum creatinine
  • INR
  • PTT
More 1st investigations to order

Investigations to consider

  • serum antiplatelet factor 4 antibodies
More investigations to consider

Treatment algorithm

INITIAL

all at-risk patients

ACUTE

trauma patients

surgical patients

medical patients

Contributors

Authors

Nathalie Routhier, MD, MSc, FRCPC

Attending Physician

Assistant Professor

University of Montreal

Montreal

Canada

Disclosures

NR declares that she has no competing interests.

Vicky Tagalakis, MD, FRCPC, MSC
Vicky Tagalakis

Associate Professor

General Internal Medicine Program Director

McGill University Division of Internal Medicine

Centre for Clinical Epidemiology of the Lady Davis Institute for Medical Research

Jewish General Hospital

Montreal

Canada

Disclosures

VT declares that she has received an investigator-initiated grant from Sanofi-Aventis. She has also received consultancy fees from and given lectures sponsored by Bristol-Myers Squibb, Pfizer, Sanofi-Aventis, and Servier. VT is an author of references cited in this topic.

Farah Zarka,

Vasculitis Clinic

Department of Medicine

Hôpital du Sacré-Coeur de Montréal

University of Montreal

Montreal

Canada

Disclosures

FZ declares that she has no competing interests.

Acknowledgements

Dr Nathalie Routhier, Dr Vicky Tagalakis, and Dr Farah Zarka would like to gratefully acknowledge Dr Vincent Bouchard-Dechêne and Dr Adi J. Klil-Drori, previous contributors to this topic.

Disclosures

VBD and AJKD declare no competing interests.

Peer reviewers

Andrew Parfitt, MBBS, FFAEM

Clinical Director

Acute Medicine

Associate Medical Director

Consultant Emergency Medicine

Guy's and St Thomas' NHS Foundation Trust

Clinical Lead and Consultant

Accident Emergency Medicine

St Thomas' Hospital

London

UK

Disclosures

AP declares that he has no competing interests.

Sudeep Shivakumar, MD

Hematologist

Thrombosis Fellow

University of Ottawa

Ottawa Health Research Institute

Ottawa

Canada

Disclosures

SS declares that he has no competing interests.

  • Guidelines

    • American Society of Hematology, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, Sociedad Peruana de Hematología, and SVH 2022 guidelines for prevention of venous thromboembolism in surgical and medical patients and long-distance travelers in Latin America
    • American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
    More Guidelines
  • Patient leaflets

    Deep vein thrombosis

    DVT and long-distance travel

    More Patient leaflets
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer